PA
Prof. Andrea Tüttenberg, MD
Chief Executive Officer / Managing Director, Chief Medical Officer, Co-Founder
ActiTrexxTherapeutic Areas
ActiTrexx Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ATreg/Actileucel (ATX-002) | Prevention of Graft-versus-Host Disease (GvHD) | Phase 1/2 |